At Bristol Myers Squibb, we operate every day with a deep and uncompromising commitment to patients in Israel. Our vision – to empower patients to overcome serious diseases through science – is the compass that guides every research endeavor, every development, and every decision we make.
The mission we are committed to at global BMS is clear: to discover, develop, and provide access to breakthrough medications for serious diseases, driven by a genuine sense of purpose and urgency to transform lives.
In Israel, we encounter the challenges faced by patients and their families every day and are committed to reducing gaps and expanding access to life-saving treatments. With a deep sense of social responsibility, we are proud of our long-standing collaboration with the Haverim L'Refuah association, which enables us to expand accessibility, promote equal opportunities in treatment, and provide hope to those who need it most.
We believe that the strength of a leading company is measured not only by its scientific achievements, but also by its ability to combine innovation with compassion, mutual responsibility, and commitment to the community. This is our way – to integrate scientific excellence with humanity, for the benefit of patients, to strengthen the healthcare system and pharmaceutical security, and to build a better and healthier future for all of us.
Dr. Lina Ziegler
CEO, Bristol Myers Squibb Israel
